Jupiter Life Line Hospitals Limited has informed regarding the Scheme of Amalgamation of Medulla Healthcare Private Limited which is wholly-owned subsidiaries of the Jupiter Life Line Hospitals Limited
JLHL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jupiter Life Line Hospitals Limited (JLHL) has announced that its Board, at a meeting held on May 09, 2025, approved the amalgamation of its wholly-owned subsidiary Medulla Healthcare Private Limited into itself under Sections 230 to 232 of the Companies Act, 2013. Since Medulla is fully owned by JLHL, no shares will be issued and no cash consideration will be paid; the shares of Medulla held by JLHL will simply be cancelled upon the scheme becoming effective. Medulla is a small, newly-incorporated entity (set up in June 2022) with negligible financials — paid-up capital of just Rs. 0.10 million and total income of Rs. 0.01 million as on March 31, 2025 — compared to JLHL's standalone net worth of Rs. 14,225 million and total income of Rs. 10,881 million. The merger is part of an internal consolidation drive aimed at simplifying the group structure, cutting compliance costs, and improving operational efficiency.
This is a routine internal restructuring with no change in JLHL's shareholding pattern and no impact on existing shareholders. Shareholders need not take any action and should not expect any material change in the company's financials or valuation, though long-term cost savings from simplified governance may be a minor positive.